Dataset Information

Total sulfane sulfur bioavailability reflects ethnic and gender disparities in cardiovascular disease.

ABSTRACT: Hydrogen sulfide (H₂S) has emerged as an important physiological and pathophysiological signaling molecule in the cardiovascular system influencing vascular tone, cytoprotective responses, redox reactions, vascular adaptation, and mitochondrial respiration. However, bioavailable levels of H₂S in its various biochemical metabolite forms during clinical cardiovascular disease remain poorly understood. We performed a case-controlled study to quantify and compare the bioavailability of various biochemical forms of H₂S in patients with and without cardiovascular disease (CVD). In our study, we used the reverse-phase high performance liquid chromatography monobromobimane assay to analytically measure bioavailable pools of H₂S. Single nucleotide polymorphisms (SNPs) were also identified using DNA Pyrosequencing. We found that plasma acid labile sulfide levels were significantly reduced in Caucasian females with CVD compared with those without the disease. Conversely, plasma bound sulfane sulfur levels were significantly reduced in Caucasian males with CVD compared with those without the disease. Surprisingly, gender differences of H₂S bioavailability were not observed in African Americans, although H₂S bioavailability was significantly lower overall in this ethnic group compared to Caucasians. We also performed SNP analysis of H₂S synthesizing enzymes and found a significant increase in cystathionine gamma-lyase (CTH) 1364?G-T allele frequency in patients with CVD compared to controls. Lastly, plasma H₂S bioavailability was found to be predictive for cardiovascular disease in Caucasian subjects as determined by receiver operator characteristic analysis. These findings reveal that plasma H₂S bioavailability could be considered a biomarker for CVD in an ethnic and gender manner. Cystathionine gamma-lyase 1346?G-T SNP might also contribute to the risk of cardiovascular disease development.

SUBMITTER: Rajpal S

PROVIDER: S-EPMC5975076 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Total sulfane sulfur bioavailability reflects ethnic and gender disparities in cardiovascular disease.

Rajpal Saurabh S Katikaneni Pavan P Deshotels Matthew M Pardue Sibile S Glawe John J Shen Xinggui X Akkus Nuri N Modi Kalgi K Bhandari Ruchi R Dominic Paari P Reddy Pratap P Kolluru Gopi K GK Kevil Christopher G CG

Redox biology 20180203

Hydrogen sulfide (H<sub>2</sub>S) has emerged as an important physiological and pathophysiological signaling molecule in the cardiovascular system influencing vascular tone, cytoprotective responses, redox reactions, vascular adaptation, and mitochondrial respiration. However, bioavailable levels of H<sub>2</sub>S in its various biochemical metabolite forms during clinical cardiovascular disease remain poorly understood. We performed a case-controlled study to quantify and compare the bioavailab ...[more]

PMID: 29413960

Similar Datasets

Project description:BackgroundAccurate forecasting of cardiovascular disease mortality is crucial to guide policy and programming efforts. Prior forecasts often have not incorporated past trends in rates of reduction in cardiovascular disease mortality. This creates uncertainties about future trends in cardiovascular disease mortality and disparities.Methods and resultsTo forecast US cardiovascular disease mortality and disparities to 2030, we developed a hierarchical bayesian model to determine and incorporate prior age, period, and cohort effects from 1979 to 2012, stratified by age, sex, and race, which we combined with expected demographic shifts to 2030. Data sources included the National Vital Statistics System, Surveillance, Epidemiology, and End Results (SEER) single-year population estimates, and US Bureau of Statistics 2012 national population projections. We projected coronary disease and stroke deaths to 2030, first on the basis of constant age, period, and cohort effects at 2012 values, as is most commonly done (conventional), and then with the use of more rigorous projections incorporating expected trends in age, period, and cohort effects (trend based). We primarily evaluated absolute mortality. The conventional model projected total coronary and stroke deaths by 2030 to increase by ≈18% (67 000 additional coronary deaths per year) and 50% (64 000 additional stroke deaths per year). Conversely, the trend-based model projected that coronary mortality would decrease by 2030 by ≈27% (79 000 fewer deaths per year) and stroke mortality would remain unchanged (200 fewer deaths per year). Health disparities will be improved in stroke deaths but not coronary deaths.ConclusionsAfter prior mortality trends and expected demographic shifts are accounted for, total US coronary deaths are expected to decline, whereas stroke mortality will remain relatively constant. Health disparities in stroke but not coronary deaths will be improved but not eliminated. These age, period, and cohort approaches offer more plausible predictions than conventional estimates.

Dataset Information

Total sulfane sulfur bioavailability reflects ethnic and gender disparities in cardiovascular disease.

Publications

Total sulfane sulfur bioavailability reflects ethnic and gender disparities in cardiovascular disease.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets